Gavin MacBeath

Directeur Scientifique

US·SEC (Form 4)

TScan Therapeutics, Inc.

Total declarations

Company

▲ Purchases (2 ops.)

€27k

▼ Sales (0 ops.)

—

Latest filing published 02 Oct 2026 for TScan Therapeutics, Inc..

Filing timeline

BuySale

Gavin MacBeath

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Positive at T+90

Median T+90

-35.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

TScan Therapeutics, Inc. 2 purchases · last 22 Sept 2021

Since each purchase

TScan Therapeutics, Inc.
Filed 22 Sept 2021 · 1858 days ago · €301
-62.5%
Entry US$7.69 · Close at T+365 US$2.88

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gavin MacBeath: trading record in brief

Gavin MacBeath is a declared insider of TScan Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 20 September 2021 to 1 October 2026, the count stands at 3 filings.

Every open-market trade on record is a purchase: 2 purchases worth €27k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.

The record was last updated on 2 October 2026 with a share grant in TScan Therapeutics, Inc. The latest purchase dates back some time: it was published 1,858 days ago, on 22 September 2021. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.